Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RS Synthesis is a private U.S.-based peptide synthesis company that provides custom peptide products and services to pharmaceutical, cosmetic, and broader life science research customers. Its offerings span research-scale custom peptide synthesis, cGMP/API peptide manufacturing, peptide library services, peptide modifications, catalog peptides, cosmetic peptides, and antibody-related services. The company appears to operate primarily as a service and manufacturing organization rather than a therapeutic drug developer, with commercial offerings available from milligram to kilogram scale. Based in Louisville, Kentucky, RS Synthesis positions itself as a global supplier for peptide R&D through commercialization support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RS Synthesis.